A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Clinical trial NCT04262804 · UNKNOWN
Trial details
- NCT number
- NCT04262804
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2021-09-03
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.